Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 USD | +3.63% | +0.22% | -32.50% |
04-12 | Uniqure N.V. Announces Paula Soteropoulos Will Not Stand for Re-Election as Non-Executive Director | CI |
04-02 | UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.50% | 214M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure Says Initial Data From Phase 1/2 Trial Support Tolerability of AMT-130 in Patients With Huntington's Disease